Ticker
GYRECompany Name
GYRE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Tangible Assets |
---|---|---|---|
6/30/2025 | $ 152.65M | $ 4.96M | $ 147.68M |
3/31/2025 | $ 129.79M | $ 5.08M | $ 124.71M |
12/31/2024 | $ 125.41M | $ 1.71M | $ 123.7M |
9/30/2024 | $ 125.24M | $ 1.66M | $ 123.58M |
6/30/2024 | $ 120.93M | $ 1.65M | $ 119.28M |
3/31/2024 | $ 122.01M | $ 1.68M | $ 120.33M |
12/31/2023 | $ 116.54M | $ 1.7M | $ 114.84M |
9/30/2023 | $ 9.96M | $ 0 | $ 9.96M |
6/30/2023 | $ 12.39M | $ 0 | $ 12.39M |
3/31/2023 | $ 18.75M | $ 0 | $ 18.75M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles
(=) Tangible Assets
Tangible Assets for GYRE THERAPEUTICS INC is calculated as follows: Assets [ $ 111.8M ] - Intangibles [ $ 0 ]
(=) Tangible Assets [ $ 111.8M ]
Minimum
Sep 30, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.47K |
---|---|
min | $ 0 |
max | $ 5.31B |
average | $ 996.29M |
median | $ 389.26M |
std | $ 1.28B |